| Ident. | Authors (with country if any) | Title |
|---|
| 000101 (2020) |
Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin Chen | Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective |
| 000109 (2020) |
Inder P. Singh [Inde] ; Shiv Gupta [Inde] ; Sanjay Kumar [Inde] | Thiazole Compounds as Antiviral Agents: An Update. |
| 000313 (2020) |
Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine] | Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro |
| 000314 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada] | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. |
| 000396 (2020) |
Junxiong Pang [Singapour] ; Min Xian Wang [Singapour] ; Ian Yi Han Ang ; Sharon Hui Xuan Tan ; Ruth Frances Lewis ; Jacinta I-Pei Chen ; Ramona A. Gutierrez ; Sylvia Xiao Wei Gwee [Singapour] ; Pearleen Ee Yong Chua [Singapour] ; Qian Yang ; Xian Yi Ng ; Rowena K. S. Yap ; Hao Yi Tan ; Yik Ying Teo ; Chorh Chuan Tan ; Alex R. Cook ; Jason Chin-Huat Yap ; Li Yang Hsu | Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review |
| 000403 (2020) |
Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie] | Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. |
| 000450 (2020) |
Subramanian Boopathi [Chili] ; Adolfo B. Poma [Pologne] ; Ponmalai Kolandaivel [Inde] | Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. |
| 000521 (2020) |
Maryam Fattahian [Iran] ; Mustafa Ghanadian [Iran] ; Zulfiqar Ali [États-Unis] ; Ikhlas A. Khan [États-Unis] | Jatrophane and rearranged jatrophane-type diterpenes: biogenesis, structure, isolation, biological activity and SARs (1984-2019). |
| 000554 (2020) |
Ting Xiao [République populaire de Chine] ; Jia-Fan Tang [République populaire de Chine] ; Ge Meng [République populaire de Chine] ; Christophe Pannecouque [Belgique] ; Yuan-Yuan Zhu [République populaire de Chine] ; Gen-Yan Liu [République populaire de Chine] ; Zhi-Qiang Xu [République populaire de Chine] ; Feng-Shou Wu [République populaire de Chine] ; Shuang-Xi Gu [République populaire de Chine] ; Fen-Er Chen [République populaire de Chine] | Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities. |
| 000558 (2020) |
Phulen Sarma [Inde] ; Nishant Sekhar [Inde] ; Manisha Prajapat [Inde] ; Pramod Avti [Inde] ; Hardeep Kaur [Inde] ; Subodh Kumar [Inde] ; Sanjay Singh [Inde] ; Harish Kumar [Inde] ; Ajay Prakash [Inde] ; Deba Prasad Dhibar [Inde] ; Bikash Medhi [Inde] | In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). |
| 000579 (2020) |
Young Sup Shin [Corée du Sud] ; Dnyandev B. Jarhad [Corée du Sud] ; Min Hwan Jang [Corée du Sud] ; Kristina Kovacikova [Pays-Bas] ; Gyudong Kim [Corée du Sud] ; Ji-Seong Yoon [Corée du Sud] ; Hong-Rae Kim [Corée du Sud] ; Young Eum Hyun [Corée du Sud] ; Amol S. Tipnis [Corée du Sud] ; Tong-Shin Chang [Corée du Sud] ; Martijn J. Van Hemert [Pays-Bas] ; Lak Shin Jeong [Corée du Sud] | Identification of 6'-β-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication. |
| 000720 (2020) |
Han Ju [République populaire de Chine] ; Siyu Xiu [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Min Shang [République populaire de Chine] ; Ruifang Jia [République populaire de Chine] ; Bing Huang [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. |
| 000799 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
| 000884 (2020) |
Undurti N. Das [États-Unis] | Can Bioactive Lipids Inactivate Coronavirus (COVID-19)? |
| 000921 (2020) |
Ennio Giulio Favalli [Italie] ; Francesca Ingegnoli [Italie] ; Orazio De Lucia [Italie] ; Gilberto Cincinelli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie] | COVID-19 infection and rheumatoid arthritis: Faraway, so close! |
| 000941 (2020) |
Camillo Sargiacomo [Royaume-Uni] ; Federica Sotgia [Royaume-Uni] ; Michael P. Lisanti [Royaume-Uni] | COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? |
| 000953 (2020) |
B. Robson | COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance |
| 000961 (2020) |
Pengfei Sun [République populaire de Chine] ; Xiaosheng Lu [République populaire de Chine] ; Chao Xu [République populaire de Chine] ; Yanjin Wang [République populaire de Chine] ; Wenjuan Sun [République populaire de Chine] ; Jianing Xi [République populaire de Chine] | CD-sACE2 inclusion compounds: An effective treatment for coronavirus disease 2019 (COVID-19). |
| 000997 (2020) |
Canrong Wu [République populaire de Chine] ; Yang Liu [République populaire de Chine] ; Yueying Yang [République populaire de Chine] ; Peng Zhang [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Yali Wang [République populaire de Chine] ; Qiqi Wang [République populaire de Chine] ; Yang Xu [République populaire de Chine] ; Mingxue Li [République populaire de Chine] ; Xingzhou Li [République populaire de Chine] ; Mengzhu Zheng [République populaire de Chine] ; Lixia Chen [République populaire de Chine] ; Hua Li [République populaire de Chine] | Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods |
| 000A15 (2020) |
Junyang Li [République populaire de Chine] ; Meicen Liu [République populaire de Chine] ; Jin Gao [République populaire de Chine] ; Yu Jiang [République populaire de Chine] ; Limin Wu [République populaire de Chine] ; Yuen-Ki Cheong [Royaume-Uni] ; Guogang Ren [Royaume-Uni] ; Zhuo Yang [République populaire de Chine] | AVNP2 protects against cognitive impairments induced by C6 glioma by suppressing tumour associated inflammation in rats. |
| 000A87 (2019) |
Yixian Liao [République populaire de Chine] ; Lizhu Chen [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Zi-Ning Cui [République populaire de Chine] ; Zhiwei Lei [République populaire de Chine] ; Hui Li [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Gaopeng Song [République populaire de Chine] | Structure-aided optimization of 3-O-β-chacotriosyl ursolic acid as novel H5N1 entry inhibitors with high selective index. |
